Huron Closes Divestiture of Life Sciences Business to Oliver Wyman
Huron has finalized the divestiture of its life sciences commercial and R&D strategy business to Oliver Wyman, part of Marsh McLennan (NYSE: MMC). This strategic move allows Huron to focus more on enhancing its industry expertise in healthcare and education, alongside advancing its technology capabilities across all segments. The transaction is expected to streamline operations, directing resources towards core business areas, thereby aiming for improved client service and operational efficiency.
- Divestiture allows Huron to concentrate on healthcare and education sectors.
- Focus on advancing technology capabilities across all operating segments.
- None.
Huron will concentrate its resources and investments in strengthening the Company’s industry expertise and capabilities in healthcare, education and the other businesses in its Business Advisory segment. In addition, the Company will continue to advance its technology expertise and capabilities across all operating segments.
For more information, please read the press release announcing the divestiture here.
ABOUT HURON
Huron is a global consultancy that collaborates with clients to drive strategic growth, ignite innovation and navigate constant change. Through a combination of strategy, expertise and creativity, we help clients accelerate operational, digital and cultural transformation, enabling the change they need to own their future. By embracing diverse perspectives, encouraging new ideas and challenging the status quo, we create sustainable results for the organizations we serve. Learn more at www.huronconsultinggroup.com.
Statements in this press release that are not historical in nature, including those concerning the Company’s current expectations about its future results, are “forward-looking” statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by words such as “may,” “should,” “expects,” “provides,” “anticipates,” “assumes,” “can,” “will,” “meets,” “could,” “likely,” “intends,” “might,” “predicts,” “seeks,” “would,” “believes,” “estimates,” “plans,” “continues,” “guidance,” or “outlook” or similar expressions. These forward-looking statements reflect the Company's current expectations about future requirements and needs, results, levels of activity, performance, or achievements. Some of the factors that could cause actual results to differ materially from the forward looking statements contained herein include, without limitation: the impact of the COVID-19 pandemic on the economy, our clients and client demand for our services, and our ability to sell and provide services, including the measures taken by governmental authorities and businesses in response to the pandemic, which may cause or contribute to other risks and uncertainties that we face; failure to achieve expected utilization rates, billing rates and the number of revenue-generating professionals; inability to expand or adjust our service offerings in response to market demands; our dependence on renewal of client-based services; dependence on new business and retention of current clients and qualified personnel; failure to maintain third-party provider relationships and strategic alliances; inability to license technology to and from third parties; the impairment of goodwill; various factors related to income and other taxes; difficulties in successfully integrating the businesses we acquire and achieving expected benefits from such acquisitions; risks relating to privacy, information security, and related laws and standards; and a general downturn in market conditions. These forward-looking statements involve known and unknown risks, uncertainties, and other factors, including, among others, those described under “Item 1A. Risk Factors” in Huron's Annual Report on Form 10-K for the year ended
View source version on businesswire.com: https://www.businesswire.com/news/home/20211102005699/en/
MEDIA CONTACT
abovis@hcg.com
INVESTOR CONTACT
investor@hcg.com
Source: Huron
FAQ
What business did Huron divest to Oliver Wyman?
What will Huron focus on after the divestiture?
What is the stock symbol for Huron?
What is the stock symbol for Marsh McLennan?
